What is dMMR and how is it diagnosed?
Lacking mismatch repair (dMMR) is a genetic alteration wherein the DNA repair system cannot repair replication errors. This leads to […]
Catégorie : Medical
Microsatellite Instability (MSI) testing should be standard of care.s
It predicts response to immunotherapy and can detect Lynch syndrome — yet in France, many patients still miss out. Why? […]
PCR vs NGS in MSI testing: the real-world trade-offs
Many clinicians still use PCR — but is it keeping up with today’s demands? This comparison shows exactly where NGS […]
September is Blood Cancer Awareness Month
Highlighting the urgent need for enhanced diagnostics in leukemia, lymphoma, and myeloma. MSInsight developed MSIcare to detect microsatellite instability (MSI) […]
September is Gynecologic Cancer Awareness Month 🎗️
Gynecologic cancers, including ovarian, endometrial, cervical, vulvar, and vaginal cancers, affect hundreds of thousands of women worldwide each year. Accurate […]
From Rare Research Tool to Global Standard: The Rise of MSI Testing
Ten years ago, Microsatellite Instability (MSI) testing was largely confined to specialized academic labs. Today, it’s at the center of […]
What is Microsatellite Instability (MSI)?
Microsatellite Instability is a genomic signature that occurs when a cell’s DNA mismatch repair (MMR) system stops working properly. 📌 […]
World Lung Cancer Day
🎗️ World Lung Cancer Day — a moment to reflect, raise awareness, and push for earlier, smarter diagnostics. Lung cancer […]
🔬 MSInsight, proud to participate in SantExpo 2025 in Paris! 🇫🇷
From May 21–23, we showcased our flagship solution, MSIcare, an AI-powered genomic analysis platform designed to detect microsatellite instability (MSI) […]
🚀 MSInsight on TV! 🚀
https://www.msinsight.tech/wp-content/uploads/2025/05/BFMTV-Lyon-Video-Clip1.mp4 We’re thrilled to share that our CEO, Arnaud Cutivet, was recently featured on **BFM LYON** (BFMTV) (Ma Santé) as […]
